Stevens Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-193,796
| Closed | -$4.94M | – | 305 |
|
|
2025
Q3 | $4.94M | Buy |
+193,796
| New | +$4.78M | 0.65% | 36 |
|
|
2025
Q2 | – | Sell |
-81,886
| Closed | -$2.08M | – | 313 |
|
|
2025
Q1 | $2.08M | Buy |
+81,886
| New | +$2.14M | 0.52% | 45 |
|
|
2024
Q4 | – | Sell |
-99,037
| Closed | -$2.87M | – | 361 |
|
|
2024
Q3 | $2.87M | Buy |
+99,037
| New | +$2.89M | 0.41% | 41 |
|
|
2024
Q2 | – | Sell |
-41,848
| Closed | -$1.16M | – | 311 |
|
|
2024
Q1 | $1.16M | Buy |
+41,848
| New | +$1.16M | 0.23% | 100 |
|
|
2023
Q3 | – | Sell |
-21,762
| Closed | -$798K | – | 316 |
|
|
2023
Q2 | $798K | Sell |
21,762
-7,251
| -25% | -$282K | 0.16% | 125 |
|
|
2023
Q1 | $1.18M | Buy |
29,013
+24,177
| +500% | +$1.04M | 0.29% | 51 |
|
|
2022
Q4 | $248K | Buy |
+4,836
| New | +$232K | 0.16% | 110 |
|
|
2022
Q2 | – | Sell |
-58,680
| Closed | -$3.04M | – | 229 |
|
|
2022
Q1 | $3.04M | Buy |
58,680
+50,446
| +613% | +$2.62M | 0.66% | 38 |
|
|
2021
Q4 | $486K | Sell |
8,234
-8,061
| -49% | -$399K | 0.11% | 167 |
|
|
2021
Q3 | $701K | Sell |
16,295
-14,522
| -47% | -$643K | 0.29% | 72 |
|
|
2021
Q2 | $1.21M | Buy |
+30,817
| New | +$1.2M | 0.35% | 49 |
|
|
2020
Q4 | – | Sell |
-43,357
| Closed | -$1.51M | – | 211 |
|
|
2020
Q3 | $1.51M | Sell |
43,357
-143,977
| -77% | -$5.05M | 0.56% | 43 |
|
|
2020
Q2 | $5.81M | Buy |
+187,334
| New | +$6.36M | 2.14% | 17 |
|
|
2019
Q4 | – | Sell |
-351,425
| Closed | -$12M | – | 749 |
|
|
2019
Q3 | $12M | Buy |
+351,425
| New | +$12.8M | 1.08% | 15 |
|
|
2018
Q2 | – | Sell |
-181,183
| Closed | -$6.1M | – | 933 |
|
|
2018
Q1 | $6.1M | Sell |
181,183
-90,854
| -33% | -$3.12M | 0.23% | 136 |
|
|
2017
Q4 | $9.35M | Sell |
272,037
-436,975
| -62% | -$14.9M | 0.36% | 78 |
|
|
2017
Q3 | $24M | Buy |
709,012
+529,401
| +295% | +$17M | 0.89% | 17 |
|
|
2017
Q2 | $5.72M | Buy |
+179,611
| New | +$5.66M | 0.21% | 146 |
|
|
2016
Q3 | – | Sell |
-777,619
| Closed | -$26M | – | 1084 |
|
|
2016
Q2 | $26M | Buy |
+777,619
| New | +$24.8M | 1.04% | 9 |
|
|
2016
Q1 | – | Sell |
-481,135
| Closed | -$14.7M | – | 1057 |
|
|
2015
Q4 | $14.7M | Buy |
+481,135
| New | +$15.1M | 0.58% | 30 |
|
|
2015
Q3 | – | Sell |
-1,050,572
| Closed | -$33.4M | – | 1159 |
|
|
2015
Q2 | $33.4M | Buy |
+1,050,572
| New | +$34.2M | 1.2% | 4 |
|
|
2015
Q1 | – | Sell |
-150,257
| Closed | -$4.44M | – | 1171 |
|
|
2014
Q4 | $4.44M | Sell |
150,257
-722,249
| -83% | -$20.7M | 0.15% | 173 |
|
|
2014
Q3 | $24.5M | Sell |
872,506
-721,264
| -45% | -$20.2M | 0.74% | 20 |
|
|
2014
Q2 | $44.9M | Buy |
+1,593,770
| New | +$45.4M | 1.2% | 2 |
|
|
2014
Q1 | – | Sell |
-1,553,651
| Closed | -$45.1M | – | 1258 |
|
|
2013
Q4 | $45.1M | Buy |
1,553,651
+1,288,044
| +485% | +$37.5M | 1.33% | 7 |
|
|
2013
Q3 | $7.24M | Sell |
265,607
-78,164
| -23% | -$2.13M | 0.21% | 138 |
|
|
2013
Q2 | $9.14M | Buy |
+343,771
| New | +$9.5M | 0.3% | 94 |
|
Other funds holding PFE
Stevens Capital Management's PFE Position: Q4 2025 in Review
Stevens Capital Management sold out of Pfizer (PFE) in Q4 2025, closing a stake of 193,796 shares — an estimated $4.94M sold.
Stevens Capital Management first reported a position in PFE in Q2 2013 and held it in 27 quarters. The position peaked at $45.1M in Q4 2013. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Stevens Capital Management reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Stevens Capital Management sold 193,796 Pfizer shares in Q4 2025, an estimated $4.94M.
- Stevens Capital Management first reported a position in Pfizer in Q2 2013 and held it in 27 quarters.
- Stevens Capital Management's Pfizer position peaked at $45.1M in Q4 2013.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Stevens Capital Management's 13F filing for Q4 2025, filed 3 Feb 2026.